Trial Profile
A Prospective, randomized comparative study of Corifollitropin Alfa Versus Daily Recombinant Fsh in poor responders undergoing IVF/intracytoplasmic sperm injection (ICSI).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Corifollitropin alfa (Primary) ; Follicle stimulating hormones (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- 09 Dec 2015 New trial record